The novel function of a key enzyme regulating tryptophan-NAD metabolism

色氨酸-NAD代谢关键酶的新功能

基本信息

  • 批准号:
    13660118
  • 负责人:
  • 金额:
    $ 2.24万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    2001
  • 资助国家:
    日本
  • 起止时间:
    2001 至 2003
  • 项目状态:
    已结题

项目摘要

Picolinate has been implicated in immune system in vitro experiments. On the other hand, quinolinate is a potent endogenous excitotoxin of neuronal cells. α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase (ACMSD ; EC 4.1.1.45) is one of the important enzymes regulating tryptophan-niacin metabolism. ACMSD seems to be able to influence directly the production of picolinate and quinolinate. In this study, we investigated the effect of acute immune stimulation on ACMSD activity and mRNA expression in rats. ACMSD mRNA was expressed in the liver and kidney, but not in the brain, lung, spleen and thymus by RT-PCR in control and LPS-treated groups. There were no significant difference between control and LPS treated rats in ACMSD activity and mRNA. Moreover we measured the tryptophan catabolite quinolinic acid level in rats fed on linoleic acid. In rats fed with 10 or 20% linoleic acid diet, ACMSD mRNA in the liver was strongly suppressed and serum quinolinic acid was significantly increased as compared with the rats fed on a fat-free diet. These results suggest that there is an inverse relationship between ACMSD activity and the production of quinolinic acid converted from tryptophan.
在体外实验中,吡啶甲酸酯与免疫系统有关。另一方面,喹啉酸是神经细胞的强内源性兴奋性毒素。α-氨基-β-羧基粘康酸-ε-半醛脱羧酶(α-amino-β-carboxymuconate-ε-semialdehyde decarboxylase,ACMSD ; EC 4.1.1.45)是调节烟酸代谢的重要酶。ACMSD似乎能够直接影响吡啶甲酸和喹啉甲酸的生产。本研究探讨了急性免疫刺激对大鼠ACMSD活性和mRNA表达的影响。RT-PCR结果显示,对照组和LPS处理组ACMSD mRNA在肝、肾中均有表达,而在脑、肺、脾和胸腺中无表达。对照组和LPS组大鼠ACMSD活性和mRNA表达无显著性差异。此外,我们还测量了喂食亚油酸的大鼠中的色氨酸分解代谢物喹啉酸水平。与无脂饲料喂养的大鼠相比,10%或20%亚油酸饲料喂养的大鼠肝脏中ACMSD mRNA被强烈抑制,血清喹啉酸显著升高。这些结果表明,ACMSD活性和色氨酸转化为喹啉酸的产量之间存在反比关系。

项目成果

期刊论文数量(14)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Fukuoka SI et al.: "Identification and expression of a cDNA encoding human alpha-amino-beta-carboxymuconate-epsilon-semialdehyde decarboxylase (ACMSD). A key enzyme for the tryptophan-niacine pathway and "quinolinate hypothesis""J. Biol. Chem.. 277・38. 35
Fukuoka SI 等人:“编码人 α-氨基-β-羧基粘康酸-ε-半醛脱羧酶 (ACMSD) 的 cDNA 的鉴定和表达。色氨酸-烟酸途径和“喹啉酸假说”的关键酶”J. Biol。化学.. 277・38.
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
江頭 祐嘉合, 笹原祥吾, 真田宏夫: "トリプトファン・ナイアシン代謝の鍵酵素α-アミノ-β-カルボキシムコン酸-ε-セミアルデヒド脱炭酸酵素(ACMSD)と免疫との関連"健康創造研究会誌. 3・1(in press). (2004)
Yukago Egashira、Shogo Sasahara、Hiroo Sanada:“色氨酸和烟酸代谢中的关键酶 α-氨基-β-羧基粘康酸-ε-半醛脱羧酶 (ACMSD) 与免疫之间的关系”健康创造研究会杂志 3。・1(正在出版)(2004)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A.Tanabe: "Purification and molecular cloning of rat 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase."Biochem.J.. 361. 567-575 (2002)
A.Tanabe:“大鼠 2-氨基-3-羧基粘康酸-6-半醛脱羧酶的纯化和分子克隆。”Biochem.J.. 361. 567-575 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
A.Tanabe: "Expression of rat hepatic 2-amino-3-carboxymuconate-6-semialdehyde decarboxylase is affected by a high protein diet and by streptozotocin-induced diabetes."J.Nutr.. 132. 1153-1159 (2002)
A.Tanabe:“大鼠肝脏 2-氨基-3-羧基粘康酸-6-半醛脱羧酶的表达受到高蛋白饮食和链脲佐菌素诱导的糖尿病的影响。”J.Nutr.. 132. 1153-1159 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
S.Fukuoka: "Identification and expression of a cDNA encoding human ACMSD : a key enzyme for the tryptophan-niacine pathway and quinolinate hypothesis."J.Biol.Chem.. 277. 35162-35167 (2002)
S.Fukuoka:“编码人 ACMSD 的 cDNA 的鉴定和表达:色氨酸烟酸途径和喹啉酸假说的关键酶。”J.Biol.Chem.. 277. 35162-35167 (2002)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

EGASHIRA Yukari其他文献

EGASHIRA Yukari的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('EGASHIRA Yukari', 18)}}的其他基金

Study on the regulatory mechanisms of neurodegenelation by tryptophan key enzymes
色氨酸关键酶调控神经退行性变机制的研究
  • 批准号:
    23580158
  • 财政年份:
    2011
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of tryptophan-niacin key enzymes in brain's immune system
色氨酸-烟酸关键酶在大脑免疫系统中的作用
  • 批准号:
    20580122
  • 财政年份:
    2008
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A novel function of tryptophan key enzyme in the brain and its regulation mechanism
脑内色氨酸关键酶的新功能及其调控机制
  • 批准号:
    17580105
  • 财政年份:
    2005
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似海外基金

Elucidation of mechanism for activity regulation of deacetylase sirtuin, by niacin nutritional status
阐明烟酸营养状况对去乙酰酶 Sirtuin 活性调节的机制
  • 批准号:
    23K16800
  • 财政年份:
    2023
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
NAPS: Niacin for Parkinson's Disease
NAPS:烟酸治疗帕金森病
  • 批准号:
    9872019
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
NAPS: Niacin for Parkinson's Disease
NAPS:烟酸治疗帕金森病
  • 批准号:
    10291779
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
NAPS: Niacin for Parkinson's Disease
NAPS:烟酸治疗帕金森病
  • 批准号:
    10417104
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
Comprehensive analysis on the effects of niacin nutritional fluctuations for metabolic regulation
烟酸营养波动对代谢调节影响的综合分析
  • 批准号:
    19K20117
  • 财政年份:
    2019
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Mobilizing anti-tumor microglia/macrophages with niacin to improve the prognosis of glioblastoma: Bench to clinical trial and back.
用烟酸动员抗肿瘤小胶质细胞/巨噬细胞来改善胶质母细胞瘤的预后:从实验台到临床试验再回来。
  • 批准号:
    368380
  • 财政年份:
    2017
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Mobilizing anti-tumor microglia/macrophages to improve the prognosis of glioblastoma: Bench to clinical trial and back
动员抗肿瘤小胶质细胞/巨噬细胞改善胶质母细胞瘤的预后:从实验台到临床试验再到回归
  • 批准号:
    366554
  • 财政年份:
    2016
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Operating Grants
Elucidating mechanisms of aging regulation via tryptophan-niacin metabolism
通过色氨酸-烟酸代谢阐明衰老调节机制
  • 批准号:
    16K21037
  • 财政年份:
    2016
  • 资助金额:
    $ 2.24万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
GPR109A 和帕金森病:烟酸在结果测量中的作用
  • 批准号:
    10174734
  • 财政年份:
    2015
  • 资助金额:
    $ 2.24万
  • 项目类别:
GPR109A and Parkinson's Disease: Role of Niacin in Outcome Measures
GPR109A 和帕金森病:烟酸在结果测量中的作用
  • 批准号:
    9674226
  • 财政年份:
    2015
  • 资助金额:
    $ 2.24万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了